臺灣汎生製藥廠股份有限公司,網站更新中,造成不便請多包涵,歡迎指教~ ~~~

Home Product ANTI-TUMOR AGENTS MEKEI Tab. (Megace)

MEKEI Tab. (Megace)

DOH PM 043470

Each tablet contains:
Megestrol acetate
...........................160 mg

< Indication >
It is indicated for the paliative treatment of advance carcinoma of the breast or endometrium.

< Dosage >
Breast cancer 160 mg daily, Endometrial cancer 40-320 mg each day, by using different dosages, for to ensure effective treatments, continue taking doses for at least 2 months.

< Package >
100’s/foil, 100’s/bot.

Subscribe to Latest NewsSubscribe to Latest News Subscribe to Merchandise NewsSubscribe to Merchandise News  
Powered by